Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2012-04-30
Original SEC Filing: Click here

---

Webplus: CO/20120430/6-K_1/2_EX-4.1/000.htm SEC Original: v310597_ex4-1.htm
Execution Version CONVERTIBLE NOTE PURCHASE among CHINA CORD BLOOD CORPORATION and KKR CHINA HEALTHCARE INVESTMENT LIMITED Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page Section 1 2 Section 2 9 Section 3 9 Section 4 14 Section 5

---

---

Webplus: CO/20120430/6-K_1/3_EX-4.2/000.htm SEC Original: v310597_ex4-2.htm
SENIOR CONVERTIBLE NOTE SECURITIES ACT CHINA CORD BLOOD CORPORATION 7% SENIOR CONVERTIBLE NOTE Original Principal Amount: US$65,000,000 Holder Principal and Issuance Date and Note Notes Other Notes Registration Rights Agreement FOR VALUE RECEIVED, China Cord Blood Corporation, an exempted company with limited liability incorporated in the Cayman Islands (the “Company”), hereby promises to pay to the order of KKR China

---

---

Webplus: CO/20120430/6-K_1/4_EX-4.3/000.htm SEC Original: v310597_ex4-3.htm
EXECUTION COPY REGISTRATION RIGHTS AGREEMENT between CHINA CORD BLOOD CORPORATION and KKR CHINA HEALTHCARE INVESTMENT LIMITED April 27 Dated Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THIS AGREEMENT 5 Section 3

---

---

Webplus: CO/20120430/6-K_1/5_EX-4.4/000.htm SEC Original: v310597_ex4-4.htm
DIRECTOR INDEMNIFICATION AGREEMENT between CHINA CORD BLOOD CORPORATION and JULIAN J. WOLHARDT Dated April 27, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Contents Page 1. Interpretation 1 2. Indemnity 3 3. Limitations on indemnity 3 4. Company’s liability 4 5. 4

---

---

Webplus: CO/20120430/6-K_1/6_EX-4.5/000.htm SEC Original: v310597_ex4-5.htm
Execution Copy INDEMNIFICATION PRIORITY AND INFORMATION SHARING AGREEMENT Agreement KKR CHINA HEALTHCARE INVESTMENT LIMITED Investor KKR Company This INDEMNIFICATION PRIORITY AND INFORMATION SHARING AGREEMENT, dated as of April 27, 2012 (this “ Company Indemnification Agreement KKR Indemnified Parties WHEREAS, the Company has entered into a Convertible Note Purchase Agreement dated as of April 12, 2012 (the “ KKR Director WHEREAS,

---

---

Webplus: CO/20120430/6-K_1/7_EX-15.1/000.htm SEC Original: v310597_ex15-1.htm
China Cord Blood Corporation Announces Completion of $65 Million Convertible Debt Financing with KKR HONG KONG, China, April 27, 2012 China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), the first and largest cord blood banking operator in China, today announced that it has successfully closed a US$65 million convertible debt financing with funds affiliated with KKR China Growth

---

---

Webplus: CO/20120430/6-K_1/1/000.htm SEC Original: v310597_6k.htm

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2012-04-30CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000